Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Rezvani

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Expert Opinion on Biological Therapy|January 16, 2008
Using allogeneic stem cell/T-cell grafts to cure hematologic malignanciesAndrew R Rezvani, Rainer Storb
Journal of Autoimmunity|February 5, 2008
Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantationAndrew R Rezvani, Rainer F Storb
Current Opinion in Hematology|October 10, 2013
Allogeneic hematopoietic cell transplantation for indolent non-Hodgkin lymphoma: indications and outcomesAndrew R Rezvani, Brenda M Sandmaier
Best Practice & Research. Clinical Haematology|June 11, 2011
Rituximab resistanceAndrew R Rezvani, David G Maloney
Expert Opinion on Pharmacotherapy|July 10, 2012
Prevention of graft-vs.-host diseaseAndrew R Rezvani, Rainer F Storb
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2019
Costs and Outcomes with Once-Daily versus Every-6-Hour Intravenous Busulfan in Allogeneic Hematopoietic Cell TransplantationSurbhi Singhal, Ted Kim, Patricia Jenkins, et al.
Nature Communications|February 1, 2022
Rare transmission of commensal and pathogenic bacteria in the gut microbiome of hospitalized adultsBenjamin A Siranosian, Erin F Brooks, Tessa Andermann, et al.
Transplantation and Cellular Therapy|April 10, 2021
Guidelines for Adult Patient Selection and Conditioning Regimens in Cord Blood Transplant Recipients with Hematologic Malignancies and Aplastic AnemiaLeland Metheny, Ioannis Politikos, Karen K Ballen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2020
Impact of Rituximab and Host/Donor Fc Receptor Polymorphisms after Allogeneic Hematopoietic Cell Transplantation for CD20<sup>+</sup> B Cell MalignanciesNoa Granot, Andrew R Rezvani, Barbara S Pender, et al.
Transplantation|May 23, 2013
Inducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic targetMasahiko Sato, Rainer Storb, Carol Loretz, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Expert Opinion on Biological Therapy|January 16, 2008
Using allogeneic stem cell/T-cell grafts to cure hematologic malignanciesAndrew R Rezvani, Rainer Storb
Journal of Autoimmunity|February 5, 2008
Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantationAndrew R Rezvani, Rainer F Storb
Current Opinion in Hematology|October 10, 2013
Allogeneic hematopoietic cell transplantation for indolent non-Hodgkin lymphoma: indications and outcomesAndrew R Rezvani, Brenda M Sandmaier
Best Practice & Research. Clinical Haematology|June 11, 2011
Rituximab resistanceAndrew R Rezvani, David G Maloney
Expert Opinion on Pharmacotherapy|July 10, 2012
Prevention of graft-vs.-host diseaseAndrew R Rezvani, Rainer F Storb
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 17, 2019
Costs and Outcomes with Once-Daily versus Every-6-Hour Intravenous Busulfan in Allogeneic Hematopoietic Cell TransplantationSurbhi Singhal, Ted Kim, Patricia Jenkins, et al.
Nature Communications|February 1, 2022
Rare transmission of commensal and pathogenic bacteria in the gut microbiome of hospitalized adultsBenjamin A Siranosian, Erin F Brooks, Tessa Andermann, et al.
Transplantation and Cellular Therapy|April 10, 2021
Guidelines for Adult Patient Selection and Conditioning Regimens in Cord Blood Transplant Recipients with Hematologic Malignancies and Aplastic AnemiaLeland Metheny, Ioannis Politikos, Karen K Ballen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2020
Impact of Rituximab and Host/Donor Fc Receptor Polymorphisms after Allogeneic Hematopoietic Cell Transplantation for CD20<sup>+</sup> B Cell MalignanciesNoa Granot, Andrew R Rezvani, Barbara S Pender, et al.
Transplantation|May 23, 2013
Inducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic targetMasahiko Sato, Rainer Storb, Carol Loretz, et al.
Pageof 7